The right choice can change based on history, medication interactions, side effects, budget, and availability
As weve explored, the journey to becoming a plasma donor involves understanding a wide range of eligibility criteria, with particular attention to medications and underlying health conditions
The safety, tolerability, pharmacokinetics and pharmacodynamics of an optimized dual GLP-1/GIP receptor agonist (BGM0504) in healthy volunteers: a dose-escalation phase I study
Patients with type 2 diabetes face 2-4 times higher cardiovascular disease risk compared to those without diabetes
Roche has pioneered targeted therapies and personalized medicine, especially in oncology and immunology, and has historically invested heavily in R&D